Back to Search Start Over

Disability evaluation in patients with Guillain-Barre syndrome and SARS-CoV-2 infection.

Authors :
Sanchez-Boluarte, Sofía S.
Aguirre-Quispe, Wilfor
Tacunan-Cuellar, Jhon
Sanchez-Boluarte, Arantxa N.
Segura-Chavez, Darwin
Source :
Frontiers in Neurology; 2023, p1-9, 9p
Publication Year :
2023

Abstract

Objective: Several cases of Guillain-Barre syndrome (GBS) associated with SARSCoV-2 infection have been described. This study illustrated the demographic, clinical, and neurophysiological characteristics of patients with GBS and COVID-19, as well as associated factors with disability at discharge. Materials and methods: A retrospective analytical observational study was conducted. It included patients diagnosed with GBS admitted in a national reference center in Peru between 2019 and 2021. Epidemiological, clinical, neurophysiological, and cerebrospinal fluid data were analyzed. A multivariate analysis, using the generalized linear model, was performed, considering the presence of disability at discharge as the dependent variable. Results: Eight-one subjects diagnosed with GBS were included. The mean age was 46.8 years (SD: 15.2), with a predominance of males (61.73%). The most frequent clinical presentation was the classic sensory-motor form in 74 cases (91.36%) with AIDP (82.35%) as the most frequent neurophysiological pattern in the group with COVID-19, while AMAN pattern predominated (59.26%) in those without COVID-19 (p = <0.000). The disability prevalence ratio at discharge between subjects with COVID-19 and those without COVID-19 was 1.89 (CI 1.06-3.34), p = 0.030, adjusted for age, sex, and neurophysiological subtype. Conclusion: The neurophysiologic subtype AIDP, and a higher disability were associated with the presence of COVID-19. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16642295
Database :
Complementary Index
Journal :
Frontiers in Neurology
Publication Type :
Academic Journal
Accession number :
169695645
Full Text :
https://doi.org/10.3389/fneur.2023.1191520